Year: 2011
Type: article
Abstract: Acute leukemia after myeloma has been attributed to exposure to alkylating agents. However, leukemia is now being seen in patients receiving lenalidomide maintenance therapy. Patients with monoclonal gammopathy of undetermined significance also have an increased risk of leukemia without ever being treated.
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1111010
Authors: Ola Landgren, Anish Thomas, Sham Mailankody
Institution: National Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: Population based studies
OpenAlex ID: W2033619649